Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa

Aditi Arya, Loick Pradel Kojom Foko, Shewta Chaudhry, Amit Kumar Sharma, Vineeta Singh
ISSN / E-ISSN
— / —
DOI
10.1016/j.ijpddr.2020.11.006 ↗
Volume · Issue · Pages
15 · — · 43-56
Publisher
Elsevier BV
Article URL
https://doi.org/10.1016/j.ijpddr.2020.11.006 ↗
Article details
Unverified
Publication date (each date has its type and source)
13 Dec 2020
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date13 Dec 2020 OpenAlex

Keywords (as given): artemisinin-based combination therapy; antimalarial drug resistance; Plasmodium falciparum; pfk13 mutations; pfcrt; pfdhfr; pfdhps; pfmdr1; artemether-lumefantrine; treatment failure; molecular markers; molecular surveillance; sub-Saharan Africa; India

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
International Journal for Parasitology: Drugs and Drug Resistance
Publication date used
13 Dec 2020 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.